Theravance Bio: 3Q Earnings Snapshot

November 5, 2019 GMT

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $58.4 million in its third quarter.

On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.05.

The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of $1.05 per share.

The biopharmaceutical company posted revenue of $12.4 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $13.3 million.

Theravance Bio shares have decreased 33% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.12, a drop of 29% in the last 12 months.



This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH